APT Medical Inc. (688617.SS)
CNY 427.19
(-1.36%)
CNY 427.19
(-1.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.18 Billion CNY | -498.38% |
| 2022 | -198.29 Million CNY | 24.63% |
| 2021 | -263.08 Million CNY | -223.79% |
| 2020 | -81.25 Million CNY | -226.26% |
| 2019 | 64.35 Million CNY | 180.18% |
| 2018 | -80.25 Million CNY | -2.39% |
| 2017 | -78.38 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -637.11 Million CNY | 46.3% |
| 2024 Q2 | -738.01 Million CNY | -15.84% |
| 2024 Q3 | -591.17 Million CNY | 19.9% |
| 2023 Q3 | -354.79 Million CNY | 39.7% |
| 2023 FY | -1.18 Billion CNY | -498.38% |
| 2023 Q4 | -1.18 Billion CNY | -234.43% |
| 2023 Q2 | -588.33 Million CNY | -54.26% |
| 2023 Q1 | -381.38 Million CNY | -92.34% |
| 2022 Q2 | -372.75 Million CNY | -1.39% |
| 2022 Q1 | -367.64 Million CNY | -39.75% |
| 2022 Q3 | -335.12 Million CNY | 10.1% |
| 2022 FY | -198.29 Million CNY | 24.63% |
| 2022 Q4 | -198.29 Million CNY | 40.83% |
| 2021 Q2 | -95.54 Million CNY | 35.76% |
| 2021 Q1 | -148.73 Million CNY | -83.05% |
| 2021 FY | -263.08 Million CNY | -223.79% |
| 2021 Q4 | -263.08 Million CNY | -260.17% |
| 2021 Q3 | -73.04 Million CNY | 23.55% |
| 2020 Q1 | 73.51 Million CNY | 14.24% |
| 2020 FY | -81.25 Million CNY | -226.26% |
| 2020 Q4 | -81.25 Million CNY | -612.64% |
| 2020 Q3 | 15.84 Million CNY | -68.95% |
| 2020 Q2 | 51.05 Million CNY | -30.56% |
| 2019 Q4 | 64.35 Million CNY | 0.0% |
| 2019 FY | 64.35 Million CNY | 180.18% |
| 2018 FY | -80.25 Million CNY | -2.39% |
| 2017 FY | -78.38 Million CNY | 0.0% |